We gratefully acknowledge the generous support provided by the conference sponsors:
Cepheid: Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics — and we’ve never looked back. The GeneXpert® System has been heralded as game-changing by healthcare leaders across the globe — enabling institutions of any size, from small medical clinics to high-volume reference laboratories and hospitals, to access the speed and accuracy of molecular diagnostics. Cepheid’s growing Xpert® test menu spans multiple clinical applications including healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology.
Irwin Mitchell: Irwin Mitchell is proud to be a long-standing corporate supporter of Group B Strep Support.
Through our work, we often see the outcomes from late diagnosis or treatment for group B Strep. As a result, we campaign for testing during pregnancy, and to prevent the early onset of GBS infection.
We understand the importance for both families and healthcare professionals of having access to good quality information about group B Strep. We’re committed to supporting the valuable work of Group B Strep Support by raising awareness, and helping to work towards better outcomes for all.
Leigh Day: Leigh Day is a specialist law firm acting exclusively for claimants. We have one of the largest and most experienced teams of medical negligence lawyers.
We have unrivalled experience in running complex and challenging medical negligence cases, and are ranked by legal directories as national leaders in the field.
We have been successfully securing settlements for clients and campaigning for access to justice and patient safety issues for over 30 years.
LabReady® is a healthcare technology company redefining the 85-year-old specimen collection process–leading to faster, more reliable diagnoses. LabReady® GBS is the world’s first and only enriched rapid test for diagnosing Group B Strep infection that prepares the sample before it arrives at the laboratory. Testing can be done in the provider’s office without the need for a lab, a clinic, or posting samples in the mail.
LabReady® GBS is CE marked and available to labs and clinics in the UK.
MinervaX: MinervaX is developing a group B Strep vaccine based on a family of surface proteins found on 99.7% of clinical isolates. It is highly immunogenic, resulting in long-lasting high titres of functionally active antibodies. The vaccine has been tested in 300 healthy adult women and is currently being tested in pregnant women in Africa.
MWE: MWE has been manufacturing innovative pre–analytical, specimen collection, and transportation medical devices, for 70 years. We are the only British manufacturer of swabs, and we have been supporting governments and customers in the UK and globally throughout the pandemic.
MWE not only provides products to the Clinical Industry, but also works closely with Food, Pharma, Forensics, Laboratories, Veterinary, the WHO, and NGOs.
All of our products meet manufacturing standards and comply with the CLSI standard M40–A2.
We also have our own product aimed towards Group B Strep, ∑–GBS™ for the direct collection and rapid processing of specimens screening for Streptococcus agalactiae.